← Medication Database
Oncology

DAURISMO

Generic: glasdegib

Manufacturer: Pfizer Inc.  ·  Program: Pfizer Patient Assistance Program

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Uninsured or underinsured; commercially insured patients not eligible

Residency

US resident

Income Threshold

Up to 300% FPL

Individual Income Limit

$43,740/year

Must be uninsured or publicly insured; commercial insurance ineligible

Program Information

Processing Time

2–4 weeks after complete application received

Delivery Method

shipped to patient

Application Method

Multiple

Reauthorization

Required, annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • proof of income
  • proof of residency
  • prescription
  • proof of insurance status

Indicated For

newly-diagnosed acute myeloid leukemia (AML) in adults 75+ or with comorbidities precluding intensive chemotherapy

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get DAURISMO (glasdegib) at Low or No Cost DAURISMO (glasdegib) is a prescription medication used to treat newly diagnosed **acute myeloid leukemia (AML)** in adults aged 75 or older, or those with health conditions that make intensive chemotherapy unsafe. This guide explains how the **Pfizer Patient Assistance Program** can provide DAURISMO for **free** to eligible patients who are uninsured or underinsured and meet income limits[1][3][6][9]. ## About DAURISMO (glasdegib) DAURISMO is the first **Hedgehog pathway inhibitor** approved by the FDA for AML. It works by blocking a signaling pathway that helps cancer cells grow, often used with **low-dose cytarabine (LDAC)**, a milder chemotherapy option. In a key clinical trial, DAURISMO plus LDAC extended median **overall survival** to 8.3 months, compared to 4.3 months with LDAC alone—a 54% reduction in death risk[9]. It's taken as a once-daily oral tablet, but it's not suitable for everyone. Common concerns include **QTc prolongation** (heart rhythm changes), so doctors monitor with ECGs, especially in patients with heart issues or certain medications. Patients should not donate blood during treatment or for 30 days after[5]. Always discuss side effects like fatigue, infections, or nausea with your doctor. DAURISMO targets older adults or those unfit for strong chemo due to age or comorbidities[7][9]. ## Who Qualifies for the Program? The Pfizer Patient Assistance Program offers **free Pfizer medicines**, including DAURISMO, to patients facing financial hardship. Key requirements: - **Uninsured or underinsured**: Commercially insured patients (e.g., job-based plans) are **not eligible**. Government programs like Medicare or Medicaid may qualify under specific rules[1][3][6]. - **Income at or below 400% of the Federal Poverty Level (FPL)**, adjusted for family size. Additional criteria apply[4]. - U.S. residency required. - Valid prescription from a doctor. **Note**: This is separate from Pfizer's co-pay programs, which are for commercially insured patients (up to $25,000 savings annually but exclude government insurance)[1][6]. ## Income Eligibility Breakdown Eligibility is based on household income relative to the **FPL**. Here's a table for 2026 (FPL updates annually; check current guidelines via the program): | Household Size | 100% FPL | 400% FPL (Max for Eligibility) | |---------------|----------|-------------------------------| | 1 | $15,060 | **$60,240** | | 2 | $20,440 | **$81,760** | | 3 | $25,820 | **$103,280** | | 4 | $31,200 | **$124,800** | | +1 person | +$5,380 | **+$21,520** | *Examples*: A single person earning ≤$60,240/year may qualify. A family of 4 ≤$124,800. Provide recent tax returns, pay stubs, or benefit letters as proof. Contact the program for exact 2026 figures and household adjustments[3][4]. ## Insurance Requirements - **Uninsured**: Fully eligible if income-qualified. - **Underinsured**: Possible if government-insured (e.g., Medicare Part D) but unable to afford copays. **Commercially insured patients are ineligible**—use Pfizer Oncology co-pay cards instead[1][3][6]. - Medicare patients: May qualify if not on Extra Help and facing high costs, but confirm with program[6]. ## Step-by-Step Application Process 1. **Get a prescription**: Ask your oncologist for DAURISMO. They handle much of the paperwork[5]. 2. **Gather documents**: - Proof of income (e.g., 2025 tax return, W-2s, pay stubs, SSI/SSDI letters). - Proof of residency (utility bill, lease). - Prescription. - Proof of insurance status (insurance card or denial letter)[3]. 3. **Apply**: Multiple methods available—call **(877) 744-5675**, visit Pfizer Oncology Together online, or have your doctor submit. Applications are free[1][3]. 4. **Submit**: Mail, fax, or upload documents. Doctor's office often assists. 5. **Wait for approval**: If approved, medication ships to doctor's office or home[3]. **Tip**: Start early—your doctor's support hub like Pfizer Oncology Together can guide you[1][8]. ## Timeline and Delivery Processing time varies (typically 2-4 weeks, but call for updates). Once approved, DAURISMO ships **free** to your doctor's office or home via specialty pharmacies. **Reauthorization is required** periodically—your doctor resubmits progress notes showing continued need (e.g., no disease progression)[3][5][7]. Initial supply covers your treatment cycle; refills need renewal. ## Alternatives if Denied or Ineligible - **Commercially insured?** Pfizer Oncology co-pay program: Up to $25,000/year savings[1][6]. - **Income too high?** State programs, NeedyMeds, or RxAssist.org. - **Government insured?** Medicare Extra Help, state pharmaceutical aid[6]. - **Other options**: Patient Access Network (PAN) Foundation, HealthWell Foundation for AML. Specialty pharmacies may offer compounded LDAC[2][5]. - **Clinical trials**: Search ClinicalTrials.gov for AML studies. Always consult your doctor—these ensure safe access. ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. **Program details can change**—contact Pfizer at (877) 744-5675 for latest info. Not medical advice; speak to your healthcare provider about DAURISMO suitability, risks (e.g., QT prolongation, embryo-fetal toxicity), and monitoring. Eligibility not guaranteed. Pfizer Inc. does not endorse this guide[1][3][5][9]. (Word count: 1028)

Program information last verified: March 30, 2026

Ready to apply for DAURISMO assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications